Whatever one may think about Solodyn’s medical merit (or lack thereof), one has to marvel at how MRX has protected the Solodyn franchise from genericization. MRX’s detailing has been so effective that 90% of current branded+generic Solodyn scripts are for the non-legacy doses where MRX’s settlments ensure protection from generic competition for several years (#msg-60357229).
Inasmuch as the non-legacy doses of Solodyn are superfluous from a strictly medical standpoint, an alternative explanation for the 90% figure above is that the MD’s who prescribe Solodyn are clueless.
News 
Market Data 
Discover 
